科学家们发现了一种逆转大脑衰老的蛋白质。
Scientists just found a protein that reverses brain aging

原始链接: https://www.sciencedaily.com/releases/2025/08/250820000808.htm

## 逆转年龄相关记忆力衰退:关键蛋白被发现 加州大学旧金山分校的研究人员发现一种蛋白 **FTL1** 是年龄相关认知能力下降的关键驱动因素,特别是影响海马体——大脑的学习和记忆中心。研究小鼠发现,FTL1 水平随着年龄的增长而 *增加*,这与脑细胞之间连接减少和记忆力受损有关。 重要的是,在年轻小鼠中人为提高 FTL1 水平,模拟了老年小鼠大脑的变化,而 *降低* 老年小鼠的 FTL1 水平则 **逆转** 了这些损害,恢复了连接并提高了记忆力表现。FTL1 似乎会阻碍神经元生长并减缓海马体细胞内的代谢。然而,刺激代谢可以抵消 FTL1 的负面影响。 这项发表在 *Nature Aging* 上的研究表明,FTL1 不仅仅是衰老的症状,而是 *导致* 衰退的关键因素。这些发现为开发疗法以阻断 FTL1 的影响并可能减轻衰老对认知功能的影响提供了有希望的途径。

## 小鼠大脑衰老逆转 – Hacker News 摘要 最近发表在《自然衰老》上的一项研究发现,操纵小鼠体内的 FTL1 蛋白可以逆转与年龄相关的认知能力下降。研究表明,铁储存、血糖控制与大脑衰老之间存在关联,降低 FTL1 水平可能恢复突触连接和记忆力。 Hacker News 上的讨论强调了小鼠衰老逆转研究成功的趋势,表明老年科学正朝着实验上可行的解决方案转变。尽管承认“在小鼠体内”的局限性——并回忆起如阿尔茨海默病淀粉样蛋白假说等过去的失望——评论员们表达了谨慎的乐观态度。 许多人指出,研究工具的日益精细以及科学界文化转变是值得希望的原因。一些人推测,生活方式因素,如饮食(减少红肉摄入)和运动,可能影响 FTL1 水平。总体情绪是,衰老正变得越来越不像一种不可避免的衰退,而更像是一个复杂的工程问题,未来可能出现解决方案。
相关文章

原文

Aging is particularly harsh on the hippocampus -- the brain region responsible for learning and memory.

Now, researchers at UC San Francisco have identified a protein that's at the center of this decline.

They looked at how the genes and proteins in the hippocampus changed over time in mice and found just one that differed between old and young animals. It's called FTL1.

Old mice had more FTL1, as well as fewer connections between brain cells in the hippocampus and diminished cognitive abilities.

When the researchers artificially increased FTL1 levels in young mice, their brains and behavior began to resemble that of old mice.

In experiments in petri dishes, nerve cells engineered to make lots of FTL1 grew simple, one-armed neurites -- rather than the branching neurites that normal cells create.

But once the scientists reduced the amount of FTL1 in the hippocampus of the old mice, they regained their youth. They had more connections between nerve cells, and the mice did better on memory tests.

"It is truly a reversal of impairments," said Saul Villeda, PhD, associate director of the UCSF Bakar Aging Research Institute and senior author of the paper, which appears in Nature Aging on Aug. 19. "It's much more than merely delaying or preventing symptoms."

In old mice, FTL1 also slowed down metabolism in the cells of the hippocampus. But treating the cells with a compound that stimulates metabolism prevented these effects.

Villeda is optimistic the work could lead to therapies that block the effects of FTL1 in the brain.

"We're seeing more opportunities to alleviate the worst consequences of old age," he said. "It's a hopeful time to be working on the biology of aging."

Authors: Other UCSF authors are Laura Remesal, PhD, Juliana Sucharov-Costa, Karishma J.B. Pratt, PhD, Gregor Bieri, PhD, Amber Philp, PhD, Mason Phan, Turan Aghayev, MD, PhD, Charles W. White III, PhD, Elizabeth G. Wheatley, PhD, Brandon R. Desousa, Isha H. Jian, Jason C. Maynard, PhD, and Alma L. Burlingame, PhD. For all authors see the paper.

Funding: This work was funded in part by the Simons Foundation, Bakar Family Foundation, National Science Foundation, Hillblom Foundation, Bakar Aging Research Institute, Marc and Lynne Benioff, and the National Institutes of Health (AG081038, AG067740, AG062357, P30 DK063720). For all funding see the paper.

联系我们 contact @ memedata.com